valproic acid and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

valproic acid has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bate, C; Williams, RSB	1

Other Studies

1 other study(ies) available for valproic acid and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

Article	Year
Valproic acid and its congener propylisopropylacetic acid reduced the amount of soluble amyloid-β oligomers released from 7PA2 cells. Neuropharmacology, 2018, Volume: 128 Topics: Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Cell Membrane Structures; Cells, Cultured; Cerebral Cortex; CHO Cells; Cholesterol; Cricetulus; Culture Media, Conditioned; Embryo, Mammalian; Enzyme Inhibitors; Epilepsy, Temporal Lobe; Gene Expression Regulation; HSP40 Heat-Shock Proteins; Humans; Membrane Proteins; Neurons; Platelet Activating Factor; Synaptophysin; Transfection; Valproic Acid	2018

Article

Year

Valproic acid and its congener propylisopropylacetic acid reduced the amount of soluble amyloid-β oligomers released from 7PA2 cells.

Neuropharmacology, 2018, Volume: 128

Topics: Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Cell Membrane Structures; Cells, Cultured; Cerebral Cortex; CHO Cells; Cholesterol; Cricetulus; Culture Media, Conditioned; Embryo, Mammalian; Enzyme Inhibitors; Epilepsy, Temporal Lobe; Gene Expression Regulation; HSP40 Heat-Shock Proteins; Humans; Membrane Proteins; Neurons; Platelet Activating Factor; Synaptophysin; Transfection; Valproic Acid

2018